151 related articles for article (PubMed ID: 11978172)
1. Therapeutic drug monitoring of lamotrigine.
Chong E; Dupuis LL
Ann Pharmacother; 2002 May; 36(5):917-20. PubMed ID: 11978172
[TBL] [Abstract][Full Text] [Related]
2. Saliva and serum concentration of lamotrigine in patients with epilepsy.
Tsiropoulos I; Kristensen O; Klitgaard NA
Ther Drug Monit; 2000 Oct; 22(5):517-21. PubMed ID: 11034255
[TBL] [Abstract][Full Text] [Related]
3. Are lamotrigine kinetics altered in menopause? Observations from a drug monitoring database.
Tomson T; Lukic S; Ohman I
Epilepsy Behav; 2010 Sep; 19(1):86-8. PubMed ID: 20708977
[TBL] [Abstract][Full Text] [Related]
4. Association between lamotrigine concentrations and ABCB1 polymorphisms in patients with epilepsy.
Lovrić M; Božina N; Hajnšek S; Kuzman MR; Sporiš D; Lalić Z; Božina T; Granić P
Ther Drug Monit; 2012 Oct; 34(5):518-25. PubMed ID: 22972536
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of lamotrigine in children in the absence of other antiepileptic drugs.
Chen C; Casale EJ; Duncan B; Culverhouse EH; Gilman J
Pharmacotherapy; 1999 Apr; 19(4):437-41. PubMed ID: 10212015
[TBL] [Abstract][Full Text] [Related]
6. Lamotrigine serum concentration in children with epilepsy.
Heyman E; Lavie R; Lahat E; Braunstein R; Bar-Haim A; Berkovitch M; Gandelman-Marton R
Pediatr Neurol; 2012 Dec; 47(6):427-30. PubMed ID: 23127263
[TBL] [Abstract][Full Text] [Related]
7. Effects of monitoring strategies on seizures in pregnant women on lamotrigine: a meta-analysis.
Pirie DA; Al Wattar BH; Pirie AM; Houston V; Siddiqua A; Doug M; Bagary M; Greenhill L; Khan KS; McCorry D; Thangaratinam S
Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():26-31. PubMed ID: 24211103
[TBL] [Abstract][Full Text] [Related]
8. Routine therapeutic monitoring of lamotrigine in epileptic patients using a simple and rapid high performance liquid chromatographic technique.
George S; Wood AJ; Braithwaite RA
Ann Clin Biochem; 1995 Nov; 32 ( Pt 6)():584-8. PubMed ID: 8579292
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data.
Hussein Z; Posner J
Br J Clin Pharmacol; 1997 May; 43(5):457-65. PubMed ID: 9159559
[TBL] [Abstract][Full Text] [Related]
10. LC method for the therapeutic drug monitoring of lamotrigine: evaluation of the assay performance and validation of its application in the routine area.
Zufía L; Aldaz A; Ibáñez N; Viteri C
J Pharm Biomed Anal; 2009 Feb; 49(2):547-53. PubMed ID: 19131204
[TBL] [Abstract][Full Text] [Related]
11. Monitoring salivary lamotrigine concentrations.
Malone SA; Eadie MJ; Addison RS; Wright AW; Dickinson RG
J Clin Neurosci; 2006 Nov; 13(9):902-7. PubMed ID: 17049864
[TBL] [Abstract][Full Text] [Related]
12. Variation in lamotrigine plasma concentrations with hormonal contraceptive monthly cycles in patients with epilepsy.
Contin M; Albani F; Ambrosetto G; Avoni P; Bisulli F; Riva R; Tinuper P; Baruzzi A
Epilepsia; 2006 Sep; 47(9):1573-5. PubMed ID: 16981875
[TBL] [Abstract][Full Text] [Related]
13. Use of Therapeutic Drug Monitoring, Electronic Health Record Data, and Pharmacokinetic Modeling to Determine the Therapeutic Index of Phenytoin and Lamotrigine.
Ku LC; Wu H; Greenberg RG; Hill KD; Gonzalez D; Hornik CP; Berezny A; Guptill JT; Jiang W; Zheng N; Cohen-Wolkowiez M; Melloni C
Ther Drug Monit; 2016 Dec; 38(6):728-737. PubMed ID: 27764025
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of therapeutic drug monitoring data for treatment of bipolar disorder with lamotrigine.
Unholzer S; Haen E
Pharmacopsychiatry; 2015 Sep; 48(6):211-4. PubMed ID: 26252722
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy.
Biton V
Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):1009-18. PubMed ID: 17125413
[TBL] [Abstract][Full Text] [Related]
16. Steady-state pharmacokinetics and bioavailability of immediate-release and extended-release formulations of lamotrigine in elderly epilepsy patients: Use of stable isotope methodology.
Polepally AR; Remmel RP; Brundage RC; Leppik IE; Rarick JO; Ramsay RE; Birnbaum AK
J Clin Pharmacol; 2015 Oct; 55(10):1101-8. PubMed ID: 25903807
[TBL] [Abstract][Full Text] [Related]
17. Determination of lamotrigine in human serum by high-performance liquid chromatography–tandem mass spectrometry.
Lee W; Kim JH; Kim HS; Kwon OH; Lee BI; Heo K
Neurol Sci; 2010 Dec; 31(6):717-20. PubMed ID: 20390433
[TBL] [Abstract][Full Text] [Related]
18. The effect of lamotrigine, a novel anticonvulsant, on interictal spikes in patients with epilepsy.
Jawad S; Oxley J; Yuen WC; Richens A
Br J Clin Pharmacol; 1986 Aug; 22(2):191-3. PubMed ID: 3530305
[TBL] [Abstract][Full Text] [Related]
19. Lamotrigine clinical pharmacokinetics.
Rambeck B; Wolf P
Clin Pharmacokinet; 1993 Dec; 25(6):433-43. PubMed ID: 8119045
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic drug monitoring of lamotrigine].
Bentué-Ferrer D; Tribut O; Verdier MC;
Therapie; 2010; 65(1):39-46. PubMed ID: 20205994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
